Harooni, Hooman <br/><br/>
Bevacizumab for graft rejection.  [electronic resource] 

 -  Ophthalmology  Oct 2007 
 - 1950 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1549-4713 
<br/><br/><label>Standard No.: </label>10.1016/j.ophtha.2007.05.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Angiogenesis Inhibitors--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Bevacizumab<br/>Conjunctiva<br/>Corneal Neovascularization--drug therapy<br/>Drug Therapy, Combination<br/>Glucocorticoids--administration & dosage<br/>Graft Rejection--complications<br/>Humans<br/>Injections<br/>Keratoplasty, Penetrating<br/>Male<br/>Prednisolone--administration & dosage<br/>Triamcinolone Acetonide--administration & dosage<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity